Development and Prospect of Genetically Engineered Pharmaceutics

Abstract:

With the rapid development of modern biology and technology, Genetically Engineered Pharmaceutics has become the most important field in modern medicinal industry. Currently, we have taken concern that the Genetically Engineered Pharmaceutics has been a subject of research. As advanced genetically engineered technology, genetic therapy, the point mutation techniques, DNA shuffling, RNA interference (RNAi) technology, the bioinformatics for genome and proteome analyses, the high throughput screening technology, etc. can be applied in the treatment of cancer, and other targeted therapies. A great deal of advanced technologies accelerates the development of genetically engineered pharmaceutics, and plays a key role in genetically engineered pharmaceutics. With the advances in genetically engineered pharmaceutics, we look forward to finding more new drugs, such as the high-value peptides, small functional molecular groups, proteins, especially antibodies, vaccines, enzymes, and therapeutic peptides. These developments continue to secure greater health outcomes of human being at all aspects in the long run. In this article, the development and prospect of Genetically Engineered Pharmaceutics are reviewed, and furthermore, the potential development and huge prospects are also presented.

• Periodical: Advanced Materials Research (Volume 746)
• Pages: 588-592
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.746.588
• Online since: August 2013
• Authors: Ya Qiong Huang, Kenneth L. White, De Shun Shi, Xu Jian Chen, Jia Zhou Li, Shi Yuan Zeng, Shi Hua Zhao, Gui Wen Ruan
• Keywords: Development, Genetic Drugs, Genetic Therapy, Genetically Engineered Pharmaceutics, Molecular Bio-Technology, Prospect

References

[1] Li Yuan. Genetically Engineered Pharmaceutics. Chemically Publishing House, Beijing (2007).

[2] The Blueprint of National Development Program in Science and Technology in Middle and Long Term (2006-2020) (Nation Issued the No.

[2005] 44）, (the Central Committee of the Chinese Communist Party and the State Council, February 9, 2006. ).

[3] Reiss T. Drug discovery of the future: the implications of the human genome project. Trends Biotechnol. 2011 Dec: 19(12): 496-499.

DOI: 10.1016/s0167-7799(01)01811-x

[4] Su J, Mazzeo J, Subbarao N, Jin T. Pharmaceutical development of biologics: fundamentals, challenges and recent advances. Therapeutic Delivery. 2011 Jul: 2(7): 865-871.

DOI: 10.4155/tde.11.58

[5] Lan Xin. The Developing status and the expectation of biopharmaceuticals in China．Journal of Heze University，2007，4．Vol 29．No．2．92-95.

[6] Narayan P. Overview of Drug product development. Current Protocols Pharmacology. 2011Dec, Chapter 7: Unite 7. 3. 1-29.

[7] Ryu DDY, Nam D H. Recent progress in biomolecular engineering. Biotechnol Prog. 2000, 16: 2-6.

[8] Li Zhe. The Appplication and development of transgenic techniques in biomedical industry in China. Chinese Journal of Pharmaceutical Technology Economics & Management. 2008. Vol. 2, No. 6, 49-52.

[9] Weng Z, Delisi C. Protein therapeutics: promises and challenges for the 21st century. Trends Biotechnol. 2002 Jan, 20(1)：29-35.

DOI: 10.1016/s0167-7799(01)01846-7